Literature DB >> 20106688

Cognitive and neuroradiological improvement in three patients with attenuated MPS I treated by laronidase.

V Valayannopoulos1, N Boddaert, V Barbier, M Le Merrer, C Caillaud, P de Lonlay.   

Abstract

Stem cell transplantation is not appropriate first-line treatment for attenuated phenotypes of mucopolysaccharidosis type I (MPS I). In three patients with attenuated MPSA I treated by laronidase, Patients 2 and 3 displayed significant cognitive improvement within 2years; Patients 1 and 3 displayed improvement on MRI scans of the brain. (c) 2010. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20106688     DOI: 10.1016/j.ymgme.2009.12.019

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  3 in total

1.  Cerebral magnetic resonance findings during enzyme replacement therapy in mucopolysaccharidosis.

Authors:  Yoshiko Matsubara; Osamu Miyazaki; Motomichi Kosuga; Torayuki Okuyama; Shunsuke Nosaka
Journal:  Pediatr Radiol       Date:  2017-07-21

Review 2.  Brain and spinal MR imaging findings in mucopolysaccharidoses: a review.

Authors:  D I Zafeiriou; S P Batzios
Journal:  AJNR Am J Neuroradiol       Date:  2012-07-12       Impact factor: 3.825

Review 3.  Cognitive outcomes and age of detection of severe mucopolysaccharidosis type 1.

Authors:  Scott D Grosse; Wendy K K Lam; Lisa D Wiggins; Alex R Kemper
Journal:  Genet Med       Date:  2017-01-26       Impact factor: 8.822

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.